A new pack size from Burgopak Healthcare & Technology has successfully achieved the US Consumer Product and Safety Commission’s F=1 for child resistance, in conformity with US regulatory standards for poison prevention packaging.
The new pack design, which was launched at the CphI show in Madrid, 9-11 October, uses the same locking mechanism as the original Burgopak child resistant design, which keeps the sliding blister tray and patient information leaflet (PIL) connected at all times – supporting better patient compliance by keeping vital patient information alongside the medication.
To open the pack, the patient pushes on two release buttons on either side of the pack with one hand while simultaneously pulling the highlighted tab with the other, so that the tray slides open to reveal the blister on one side with the PIL on the other.
The new pack, dimensions 100x72x15mm, can accommodate aluminium or PVC blisters sized up to 70x57x9mm, with the maximum tablet/capsule count dependant on exact product specifications.
The UK-based company reports that the new format achieved a pass rate of 96% for child resistance and 99% for senior friendly effectiveness during certified testing, while in a separate certified test it achieved 98% for child resistance and 98% for senior friendly.
“This success through two separate client tests of the packaging format clearly demonstrates the pack’s robustness in design and function, while also being clear testament to Burgopak’s commitment to innovation and design excellence,” the company says.
A new, classified ‘5’, tear resistant plastic material used for the new pack is said to be “completely recyclable”, and to differ from other tear resistant boards made with plastic laminates that make recycling or composting difficult.
Burgopak child resistant medicines packaging